智通财经APP讯,绿新生物科技(01084)发布公告,于2025年财政年度,本公司预期录得本公司拥有人应占净利润不超过人民币800万元,而截至2024年12月31日止年度的本公司拥有人应占净利润约为人民币6220万元。本集团的净利润转差主要由于本集团主要亲水胶体产品类别的价格及销量下降,导致2025年财政年度的收益及毛利减少。
智通财经APP讯,绿新生物科技(01084)发布公告,于2025年财政年度,本公司预期录得本公司拥有人应占净利润不超过人民币800万元,而截至2024年12月31日止年度的本公司拥有人应占净利润约为人民币6220万元。本集团的净利润转差主要由于本集团主要亲水胶体产品类别的价格及销量下降,导致2025年财政年度的收益及毛利减少。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.